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Progress in the performance of HIV early
infant diagnosis services in Zambia using
routinely collected data from 2006 to 2016
Jasleen Singh1, Suzanne Filteau1, Jim Todd1 and Sehlulekile Gumede-Moyo1,2*
Abstract
Background: Early diagnosis and treatment initiation of HIV-infected infants can greatly reduce the risk of infant
mortality. The WHO recommends testing HIV-exposed infants at 6 weeks of age and immediate initiation of
antiretroviral therapy if positive. This study aimed to determine the feasibility of using an electronic health records
system to evaluate the performance of Zambia’s HIV Early Infant Diagnosis services.
Methods: A retrospective analysis of routinely collected data from the Zambian SmartCare database was performed
for the period January 2006 to December 2016. The study population includes all HIV-infected infants (n = 32,593)
registered during this period on treatment for HIV. Univariable logistic regression was conducted to identify factors
associated with later infant testing and treatment initiation.
Results: The mean age at infant HIV test decreased from 10.10 months in 2006 to 3.49 months in 2016. Infants born
in 2015 were almost 4 times more likely to be tested under 2 months of age compared to infants born in 2006 (OR:
3.72, p-value: < 0.001). The mean time from diagnosis to treatment initiation decreased from 220 days in 2006 to 9
days in 2015. There was substantial regional variability with infants in the provinces of Copperbelt, Luapula and
Southern performing best in outcomes and Eastern, Lusaka and Western performing the worst.
Conclusions: HIV-exposed infants born more recently have significantly better outcomes than infants born a
decade ago in Zambia, which could be as a result of increased attention and funding for HIV programmes.
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Background
Early diagnosis and treatment initiation of HIV-infected
infants with antiretroviral therapy (ART) can reduce the
risk of early infant mortality by 76% [1]. However, treat-
ment for HIV-infected children lags considerably behind
adult treatment and without treatment approximately
50% of HIV-infected infants die before the age of two
[2]. The World Health Organisation (WHO) recom-
mends testing HIV-exposed infants by 6 weeks of age
and immediate initiation of ART if positive. Despite
these recommendations infants are lost at every step of
the early infant diagnosis cascade [3].
Zambia has been using the electronic health records
system SmartCare for the routine collection of HIV data
since 2004. SmartCare was developed to improve con-
tinuity of care and provide timely data on maternal and
child health HIV interventions for public health pur-
poses. To date no analysis of the paediatric HIV data has
been performed. This study was a retrospective analysis
of routinely collected data from the SmartCare database
over the period 2006 to 2016, to determine if infants are
being tested and initiated on treatment in the correct
timeframe. This information can be used to inform deci-
sions on improving the provision of early infant diagno-
sis services in Zambia.
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Methods
Study design
This retrospective analysis of routinely collected data
was conducted as part of the SEARCH (Sustainable
Evaluation through the Analysis of Routinely Collected
HIV data) project which aims to support the utilisation
of routinely collected HIV data. The SEARCH project is
collaboration between the London School of Hygiene
and Tropical Medicine and the Ministries of Health in
Zambia and Tanzania. The data source was SmartCare,
one of the largest electronic patient monitoring systems
in Africa. Introduced as a pilot project in 2004 by the
Zambian Ministry of Health with funding from the US
Centers for Disease Control (CDC), it has now been
rolled out across all ten provinces of Zambia and is used
to monitor and plan improvements in the country’s HIV
services. All facilities in Zambia wishing to dispense
ART are required to use SmartCare. Since 2005 Smart-
Care has been deployed to over 800 facilities in 94 dis-
tricts, with an enrolment above 900,000 patients. This
represents approximately 40% of all clinics in Zambia;
these are the largest and busiest ART clinics and the re-
quirement to join SmartCare if clinics wish to prescribe
ART means that most Zambian patients on ART care
captured in SmartCare databases [4].
Data was extracted by a SEARCH team member from
the Zambian SmartCare database modules, Paediatric
ART and Under 5 Registration, between the years 2006
and 2016 using a standardised data extraction form. The
study population includes all HIV-infected infants regis-
tered during this period on treatment for HIV. Age at
infant HIV test was determined by linking the Under 5
Registration module (which has infant date of birth) and
Paediatric ART module (which has date of infant HIV
test). Infants are registered as independent patients from
their mothers and the system does not have a link be-
tween the mother and infant pairs; therefore, informa-
tion could not be collected on the mother’s treatment,
on the proportion of HIV-exposed infants who tested
HIV-negative, or on HIV-exposed infants who missed
both testing and provision of ART. For this reason, we
are focusing this analysis solely on HIV-infected infants
born between January 2006 and December 2016 who
have received ART.
Statistical methods
Categorical variables were summarised by frequencies
and percentages and continuous variables by histograms.
Univariable and multivariable logistic regression were
conducted with “age at HIV test” and “time from diag-
nosis to treatment initiation” as the dependent variables
and the following independent variables: infant sex,
province, year of birth, and season of birth. Season were
defined as early dry (June to August); late dry
(September to November); early rainy (December to
February) and late rainy (March to May).
Odds ratios with 95% confidence intervals were calcu-
lated to identify risk factors for age at test under 2
months and time from diagnosis to treatment under 2
weeks. For the variable ‘province’ Lusaka was chosen as
the reference group because it is the most populous
province, and it contains the capital city where the
SmartCare project was first rolled out so has the largest
number of registered infants. Although multivariable
analysis was also conducted for all variables to display
adjusted odds ratios, the results showed little difference
and so only the univariable analysis results are included
in this paper. All analysis was performed using STATA
14 and graphics were produced using STATA and
Microsoft Excel.
Results
A total of 32,593 HIV-infected infants on ART in
Zambia were identified from SmartCare over the period
2006 to 2016. The number of infants in the database on
ART increased from 1761 in 2006 to peak at 3720 in
2009 and then steadily decreased to 108 in 2016. Main
comparisons over time used 2015 since there were too
few infants listed in 2016 for age at testing and none for
time to treatment initiation.
Age of diagnosis
For the outcome ‘age at infant HIV testing’, 20,260
(62.16%) infants had complete data recorded. Looking at
the country as a whole, the mean age at HIV testing has
steadily decreased from 10.10 months for infants born in
2006 to 3.49 months in 2016 (Fig. 1). Infants born in
2015 were more likely to be tested under 2 months of
age compared to infants born in 2006 (OR: 3.72, p-value:
< 0.001). For infants born in 2016 an even greater associ-
ation was found (OR: 5.62, p-value: < 0.001), but this re-
sult must be viewed with some caution as there were far
fewer infants in the database for the year 2016 (n = 108)
than 2015 (n = 386).
Considering all years together, infants in all provinces,
especially Western province (OR: 0.21, p-value: < 0.001)
were less likely to be tested under 2 months of age as
compared to infants in Lusaka; an exception was South-
ern province which had an increased odds (OR: 1.83,
p-value: 0.001). Figure 2 shows the percentage of HIV
tests performed within 2 months of birth in the years
2010 and 2015 by province. All provinces show an over-
all improvement, particularly Copperbelt, Luapula and
Southern. The years 2010 to 2015 were chosen for the
comparison to coincide with the changes in prevention
of mother-to-child transmission (PMTCT) guidelines in
Zambia over this period, as discussed below.
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Infants born in the late dry season were more likely to
be tested within 2 months than infants born in the early
dry season (OR 1.39; p value: < 0.001) (Table 1). There
was no association found for sex.
Time to ART initiation
For the outcome ‘time from diagnosis to ART initiation’,
10,881 (33.38%) infants had complete data recorded. At
the country level the mean time from diagnosis to start-
ing treatment has decreased significantly from 220 days
for infants born in 2006 to 9 days in 2015 (Fig. 1). In-
fants born in 2015 were more likely to start treatment in
under 2 weeks compared to infants born in 2006 (OR
2.29; p value: < 0.001).
Infants in all provinces had an increased likelihood of
starting treatment within 2 weeks as compared to
Lusaka, despite being less likely to be tested under 2
months. Luapula showed the biggest difference (OR:
3.83, p-value: < 0.001). The provinces showing the most
improvement from 2006 to 2015 were Copperbelt,
Fig. 1 Mean age at HIV test and time from diagnosis to treatment initiation by year of birth. Blue line is Age at HIV Test and the Red line is the
Time from diagnosis to treatment initiation
Fig. 2 Percentage of HIV tests performed within 2 months of birth by province in 2010 and 2015.The percentages represent the proportion of
infants who were tested within 2 months of birth by province in 2010 and 2015.NB//There was no 2015 data for North-Western province. The
other missing province is Muchinga province which was newly created in 2011 and is not included in this database
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Central and Northern. Female infants were slightly more
likely to start treatment in under 2 weeks compared to
males (OR: 1.10; p value: 0.004). Season showed no sig-
nificant association.
Discussion
In Zambia the age at infant HIV test has shown a steady
decline, with the exception of the period 2010 to 2013
which showed a slight increase. This period coincides
with the implementation of new WHO treatment guide-
lines for PMTCT. Changes in WHO recommendations
over the past decade on when to initiate ART in preg-
nant women have had major implications for the deliv-
ery of HIV services, and help explain the trends in
service delivery. From 2010 Zambia adopted Option A, a
complex guideline consisting of different maternal treat-
ment regimens during pregnancy, labour and postpar-
tum as well as infant prophylaxis [5]. This complexity of
regimen changes, combined with the need for regular
clinic visits in early infancy, led to high attrition rates
and infants receiving improper doses of daily Nevirapine
[6]. Option B+ which was adopted in 2013 [7] removed
this barrier by recommending treating all pregnant
women with lifelong ART regardless of CD4 count. By
simplifying the process considerably, in Malawi (where it
was first trialled), switching to Option B+ led to a
five-fold increase in the number of pregnant women en-
rolled on ART in the first quarter of implementation [8].
Table 1 Univariable analysis results for sex, season, province and year of birth
Variable Age at test Time from diagnosis to ART Logistic regression for testing at <
2months
Logistic regression for time from diagnosis
to ART < 2 weeks
< 2months n (%) < 2 weeks n (%) OR 95% CI P-value OR 95% CI P-value
Sex
Male 550/10,537 (5.2) 2249/10,537 (21.3) 1.00 – – 1.00 – –
Female 603/11,185 (5.4) 2568/11,158 (23.0) 1.03 0.92, 1.17 0.573 1.10 1.03, 1.17 0.004
Season
Early dry 914/5254 (17.4) 1478/5254 (28.1) 1.00 – – 1.00 – –
Late dry 946/4168 (22.7) 1135/4168 (27.2) 1.39 1.26, 1.54 < 0.001 0.96 0.87, 1.05 0.333
Early rainy 926/5364 (17.3) 1509/5364 (28.1) 0.99 0.90, 1.10 0.856 1.00 0.92, 1.09 0.999
Late rainy 912/5474 (16.7) 1611/5474 (29.4) 0.95 0.86, 1.05 0.311 1.07 0.98, 1.16 0.137
Province
Lusaka 365/5394 (6.8) 822/5394 (15.2) 1.00 – – 1.00 – –
Central 94/2288 (4.1) 688/2288 (30.1) 0.59 0.47, 0.74 < 0.001 2.39 2.13, 2.69 < 0.001
Copperbelt 294/4778 (6.2) 1648/4778 (34.5) 0.90 0.77, 1.06 0.210 2.93 2.66, 3.22 < 0.001
Eastern 59/2072 (2.8) 431/2072 (20.8) 0.40 0.31, 0.53 < 0.001 1.46 1.28, 1.66 < 0.001
Luapula 56/1341 (4.2) 547/1341 (40.8) 0.60 0.45, 0.80 0.001 3.83 3.36, 4.37 < 0.001
Northern 57/983 (5.8) 350/983 (35.6) 0.85 0.64, 1.13 0.262 3.08 2.65, 3.57 < 0.001
North-Western 25/883 (2.8) 244/883 (27.6) 0.40 0.27, 0.61 < 0.001 2.12 1.80, 2.50 < 0.001
Southern 394/3366 (11.7) 718/3366 (21.3) 1.83 1.57, 2.12 < 0.001 1.51 1.35, 1.69 < 0.001
Western 24/1577 (1.5) 285/1577 (18.1) 0.21 0.14, 0.32 < 0.001 1.27 1.06, 1.42 0.007
Year of birth
2006 220/1709 (12.9) 340/1709 (19.9) 1.00 – – 1.00 – –
2007 412/2619 (15.7) 547/2619 (20.9) 1.26 1.06, 1.51 0.009 1.06 0.91, 1.24 0.430
2008 528/3475 (15.2) 790/3475 (22.7) 1.21 1.02, 1.44 0.025 1.18 1.03, 1.37 0.020
2009 683/3678 (18.6) 861/3678 (23.4) 1.54 1.31, 1.82 < 0.001 1.23 1.07, 1.42 0.004
2010 675/2718 (24.8) 726/2718 (26.7) 2.24 1.89, 2.65 < 0.001 1.47 1.27, 1.70 < 0.001
2011 446/1812 (24.6) 612/1812 (33.8) 2.21 1.85, 2.64 < 0.001 2.05 1.76, 2.40 < 0.001
2012 191/1384 (13.8) 564/1384 (40.8) 1.08 0.88, 1.33 0.450 2.77 2.35, 3.26 < 0.001
2013 186/1352 (13.8) 605/1352 (44.7) 1.08 0.88, 1.33 0.474 3.26 2.76, 3.85 < 0.001
2014 171/1019 (16.8) 548/1019 (53.8) 1.36 1.10, 1.70 0.005 4.68 3.90, 5.62 < 0.001
2015 137/386 (35.5) 140/386 (36.3) 3.72 2.87, 4.83 < 0.001 2.29 1.80, 2.92 < 0.001
2016 49/108 (45.4) 0/108 (0.0) 5.62 3.71, 8.51 < 0.001 – – –
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When Zambia announced its policy for universal ART
in 2015, there was an increase in the volume of patients
initiating on ART [9]. Zambia has made progress to-
wards elimination of HIV mother-to-child transmission
with a reduction in new HIV infections among children
from 10,000 in 2010 to 8900 in 2016. This could be as
result of improved coverage of pregnant women living
with HIV accessing antiretroviral medicines to 86% [10].
In our study we were not able to calculate the MTCT
rate because the SmartCare database does not have in-
formation on the HIV exposed infants who are not on
ART.
All provinces showed a subsequent reduction in age at
test between 2013 and 2015 with the implementation of
Option B+, in which all pregnant women with HIV are
offered lifelong ART regardless of CD4 count [11]. The
progress could also be attributed to Option B+ as previ-
ous studies have concluded that children born to women
who received ART are less likely to be lost to follow-up
and more likely to be tested for HIV [12–14]. This sug-
gests that under Option B+ mothers and their infants
are more likely to be attached to the health care system.
Therefore efforts have to be made to ensure that the in-
fants who are tested and initiated are retained in care. In
Tanzania, 61% of infants receiving treatment were lost to
follow up at the time of review, despite the high propor-
tion of guardians and parents who returned for PCR re-
sults (92% in 2010 and 98% in 2011) [15]. The results
were consistent with a study from Malawi were 48% of
the HIV-exposed infants were declared lost to follow up
(LTFU) in the database although 96% of the them in the
cohort had their PCR test done at 24 months [16].
Hence despite the reduction in the age of testing the
progress of EID must be enhanced by ensuring continu-
ity in care. In Zambia the estimated percentage of chil-
dren (aged 0–14 years) living with HIV receiving ART, in
2015 was 61% [17], 3% lower than the adult coverage.
An effective EID service should achieve the following:
identify all HIV-exposed infants, provide HIV testing
and ensure return of results in a timely manner; retain
HIV-exposed infants and their mothers in care; and
identify all HIV-infected infants and link them to treat-
ment services to ensure timely initiation of ART [18].
Our data set could not allow us to effectively analyse all
these steps hence our conclusion of the progress of EID
could have been overestimated as only 33.38% infants
had complete data recorded. The poor data quality
might have an effect on the external validity of the study.
Hence the reasons for poor data quality have been quali-
tatively explored (Gumede-Moyo et al. submitted). It is
also likely that poor data entry over these years has
impacted the results; SmartCare has evolved from a
system solely used to track patients into an extensive
database of all patients receiving ART in the country.
This has resulted in a large amount of data being col-
lected for each patient which is very time consuming
for the clinician, who often omits collecting data for
certain fields they deem irrelevant to their patient’s
care. In addition, power outages in remote areas of
Zambia are a major problem and can occur for pro-
longed periods of time during the day, limiting the
time that data can be entered into the system. This
means that data collection is often not up to date
and this could contribute to the apparently poor per-
formance of Western province.
Our study is the first to attempt to analyse the pro-
gress of EID using the SmartCare database as a source
for exposed infants on ART dataset. A more comprehen-
sive dataset of the HIV status of all exposed infants
could have been obtained from the ANC and Under 5
paper registers. However, the majority of studies using
paper based routine data have also acknowledged the
common problem of missing data [19]. This could be as-
sumed to be one of the causes of under-utilisation of
routinely collected data which was observed by Munthali
et al. [20].
The best performing provinces in 2015 (Fig. 2) for
‘percentage of tests performed within 2 months of birth’
were Luapula, Southern and Copperbelt; surprisingly
Lusaka was the second worse performing province after
Western. Of the nine provinces of Zambia (excluding
Muchinga province which was created in 2011 and not
included in this database), Lusaka and Copperbelt are
predominantly urban whereas the remaining are pre-
dominantly rural [21]. Previous studies have shown that
the burden of HIV is highest in Zambia’s ‘urban poor’
[22, 23], and indeed data from the latest Zambian 2013–
14 DHS showed that Lusaka and Copperbelt have the
highest adult HIV prevalence, at 16.3 and 18.2% respect-
ively [24]. Despite the similar HIV prevalence and
population sizes, Copperbelt saw a more dramatic im-
provement in age at infant testing between 2013 and
2015 than Lusaka. The stark difference between the per-
formance of Copperbelt and Lusaka is also seen in the
percentage of infants tested under 2 months of age,
which was amongst the highest in Copperbelt in 2015
compared to 2010, but rose much less in Lusaka during
the same period. This regional variability seen could be
attributed to the concentration of donor funded pro-
grammes in the various provinces. Despite Zambia’s
classification as a lower-middle income country, it re-
mains heavily dependent on external donors to finance
its national HIV response. PEPFAR and the Global Fund
account for 95% of donor funding for HIV care [25].
Given external aid makes up the bulk of HIV funding in
Zambia, it is possible that decisions on which areas of
the country to target may influence the trends in HIV
outcomes we have seen at a provincial level.
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Infants born in the early dry season tended to be
tested earlier compared to infants born in the late dry
season, although there was no association found be-
tween dry and rainy seasons. Season was chosen as a
variable of interest because previous studies in
Sub-Saharan Africa have shown an association between
being born in the rainy season and poorer outcomes for
HIV-exposed infants [26, 27]. Reasons suggested for the
higher mortality experienced by infants born in the rainy
season include a more contaminated water supply from
the rains and food scarcity in the period preceding the
harvest [28, 29].
Study limitations
This research has shown that routinely collected data of-
fers a valuable opportunity for the near real-time surveil-
lance of large quantities of data. The SmartCare
database of registered infants receiving ART represents a
robust sample of the population under study over the
stated time period, although we recognise there was a
steady decrease in the numbers of infants registered
onto SmartCare from 2009 onwards. The large amounts
of missing data did not only introduce bias but also
compromised the statistical power of a study. Other lim-
itations with using this database are that the database
was designed for practical use by healthcare workers and
not research so the variables collected are limited to
those deemed most useful for the clinical care of pa-
tients. In addition, mother-infant pairs are not linked
within SmartCare, and so the analysis was restricted to
HIV-infected infants on ART and we were not able to
analyse outcomes for HIV-exposed uninfected infants.
This would be valuable information for any future as-
sessment of mother-to-child HIV transmission preven-
tion and control programs in Zambia.
Conclusions
Early infant diagnosis of HIV is essential to achieve
prompt treatment initiation and reduce infant mortality.
Infants born more recently have better clinical HIV care
than infants born a decade ago in Zambia, which could
be as a result of more inclusive treatment eligibility
guidelines. Provincial variability in the performance of
early infant diagnosis services is substantial. Further re-
search is needed on the reasons for such stark regional
disparities in HIV service provision in Zambia, and on
addressing missed opportunities for infant testing.
sation.
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